PT Prodia Diagnostic Line Tbk (IDX:PRDL)

Market Cap	592.59B
Revenue (ttm)	74.37B +26.8%
Net Income	16.99B
EPS	13.93
Shares Out	1.74B
PE Ratio	24.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,280,100
Open	398.00
Previous Close	340.00
Day's Range	398.00 - 424.00
52-Week Range	120.00 - 424.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IDX:PRDL

PT Prodia Diagnostic Line Tbk manufactures in vitro diagnostic medical devices in Indonesia. The company offers various products for clinical chemistry, hematology, immunoassay, biomolecular diagnostics, rapid diagnostic tests, and urinalysis. It also offers reagents, calibrators and controls, instruments, and kits. The company was formerly known as PT DiaLine Systems Indonesia and changed its name to PT Prodia Diagnostic Line Tbk in April 2011. PT Prodia Diagnostic Line Tbk was founded in 2010 and is based in Bekasi, Indonesia.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Employees: 55
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PRDL

Financial Performance

In 2025, IDX:PRDL's revenue was 74.37 billion, an increase of 26.79% compared to the previous year's 58.66 billion. Earnings were 16.99 billion, an increase of 69.93%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 15, 2026

Data Sources Report a data error